Could a New Approach to Chemotherapy Change the Future of Pancreatic Cancer?

https://www.podbean.com/media/share/pb-bwcvz-1ae0c7c

Dr. Kessler, a member of City of Hope’s multidisciplinary pancreatic cancer team, joins us on Living Hope: Your Journey with Pancreatic Cancer to discuss innovative approaches to pancreatic cancer treatment, including the RenovoCath. We also explore the importance of collaborative, team-based care and the growing reasons for hope for patients and families facing pancreatic cancer.

Pancreatic cancer is often diagnosed at an advanced stage, leaving many patients with limited treatment options and difficult decisions to navigate. Yet researchers and physicians continue to advance the field, developing new therapies and technologies designed to improve outcomes, expand treatment possibilities, and enhance quality of life.

In this episode, we take a closer look at the RenovoCath, a first-of-its-kind FDA-cleared device that delivers chemotherapy directly to the tumor. Dr. Kessler explains how this innovative approach differs from traditional systemic chemotherapy and why it has generated excitement among clinicians and patients alike.

We also discuss the value of multidisciplinary pancreatic cancer care and how collaboration among specialists can help ensure patients receive comprehensive, personalized treatment. Most importantly, we explore the progress being made in pancreatic cancer care and the reasons for optimism as new therapies and treatment strategies continue to emerge.

 

 

 

Leave a comment